BiotechTube
Home/Noxopharm/Dr Gisela Mautner
DG

Dr Gisela Mautner

Chief Executive Officer and Managing Director

Noxopharm

Therapeutic Areas

OncologyImmunologyInflammationAutoimmune

Noxopharm Pipeline

DrugIndicationPhase
Veyonda®Various cancers (investigational)Phase 1